Kyowa Kirin and Knight Therapeutics Enter Into Exclusive Distribution Agreement for POTELIGEO® for Cutaneous T-Cell Lymphoma Patients Across Latin America
Knight Therapeutics Enters into Exclusive Distribution Agreement with Kyowa Kirin International for Poteligeo®
Knight Therapeutics Inc. places No. 345 on The Globe and Mail's eighth annual ranking of Canada's Top Growing Companies
Heliostar Metals to Present at the Precious Metals & Critical Minerals Virtual Investor Conference October 14
Precious Metals & Critical Minerals Virtual Investor Conference Agenda Announced for October 13th - 15th
